Navigation Links
Vicor Technologies' CEO David H. Fater to Present Live, Online at RetailInvestorConferences.com
Date:5/27/2011

BOCA RATON, Fla., May 27, 2011 /PRNewswire/ -- Vicor Technologies, Inc. (OTCBB: VCRT) today announced that CEO David H. Fater will present at RetailInvestorConferences.com.  Vicor Technologies is a biotechnology company focused on the commercialization of its PD2i Analyzer™, an innovative, non-invasive diagnostic used to risk stratify specific target populations for future pathological events, including diabetics for the presence of diabetic autonomic neuropathy (DAN), cardiovascular disease patients for death resulting from arrhythmia or congestive heart failure, and trauma victims for imminent death absent immediate lifesaving intervention. DATE:

June 2, 2011TIME:

5:00pm EDTLINK:

www.retailinvestorconferences.com > red "register/ watch event now" buttonThis will be a live, interactive, online event during which investors are invited to ask the company questions in real-time, both in the presentation hall and at Vicor's "virtual trade booth." For those unable to join the live event, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About RetailInvestorConferences.comRetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire, and MUNCmedia is the first monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.  Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's
'/>"/>

SOURCE Vicor Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ethicon Endo-Surgery Completes Divestiture of Breast Care Business to Devicor Medical Products
2. Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobes Gamma Detection Devices
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Beamz Interactive, Inc. (OTCQB: BZIC), a leading ... that it has signed an agreement with RSL ... innovative prosthetic, orthotic and assistive technology products and ... RSL Steeper will promote and supply the Beamz ... within UK residential care facilities through its Assistive ...
(Date:12/17/2014)... Dec. 17, 2014  IGI Laboratories, Inc. (NYSE MKT: ... of its offering of $125 million aggregate principal amount ... The Notes were offered and sold only to qualified ... Act of 1933, as amended (the "Securities Act"). ... of 3.75% per year, payable semiannually in arrears on ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... Jan. 8, 2012  Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) announced today ... trial of its fully human monoclonal antibody against VEGF-C, ... The Phase 1 study will examine the safety ... with advanced solid tumours who have no other standard ...
... Jan. 7, 2012  Neurocrine Biosciences, Inc. (Nasdaq: ... founder and member of the Board of Directors, Wylie ... was a thoughtful leader with an incredible scientific mind ... by his terrific wit and disarming good nature.  He ...
Cached Medicine Technology:Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 2Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 3Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 4Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 5
(Date:12/15/2014)... Palm Beach, FL (PRWEB) December 15, 2014 ... Care , knows that holidays can be a daze of ... From slips and falls while decking halls, to burns when ... plenty of holiday hazards that can happen at any time. ... for pain, MD Now has made a list of helpful ...
(Date:12/15/2014)... December 15, 2014 OutMarket , ... released “ Social Media Cheat Sheets ,” a guide ... that drives results on the top ten social media ... It helps drive awareness, engagement, and customer service. It ... to make an impact on new networks and weather ...
(Date:12/15/2014)... HealthDay Reporter FRIDAY, Dec. 12, 2014 ... millions of American women who have migraine: The debilitating headaches ... no association between migraine and breast cancer risk," said lead ... Medical School. "There is no positive association, so there is ... either." About 18 percent of American women and 6 ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss ... which is contributing to the growth in the global audiological ... of hearing loss and balance disorders are known as audiological ... speaker and amplifier. The global market is expected to grow ... period from 2014 to 2019. Some of the factors which ...
(Date:12/15/2014)... Austin, TX (PRWEB) December 15, 2014 ... with offices in 26 countries in North and South ... begun accepting responses from industry participants for its 2015 ... survey in order to identify upcoming business and market ... industry respondents. , The survey targets areas including:, ...
Breaking Medicine News(10 mins):Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2
... risk of deaths from advanced prostate cancer is to catch// ... suggests that effective screening can prevent as much as 35% ... in men and is the second leading cause of death ... cancers are discovered when they have already spread to other ...
... clinical trials support the enhanced bioavailability// of CoQ10 delivered ... manufacturers of CoQ10 products. ,Increasing its bioavailability, ... and food makers to use lower dosages, therefore saving ... food-grade emulsifiers and solvents to trap water droplets in ...
... to be able to block the HIV virus from entering human ... major step forward in treatment of HIV. ,Scientist from ... fight against the AIDS virus. The research headed by Hiroaki Mitsuya ... States. The patients took 0.02 ounces of AK602 twice a day ...
... A study done by the researchers of Ohio State University ... your diet, you tend to prosper as well. ,The ... gain are quite strong among white female population of America. ... lost weight, but this is not particularly true for black ...
... infants with lung problem are often treated with inhaled nitric ... that this therapy does not reduce the chances of death ... of opinion that premature babies who weigh less than 1.5kgs ... are the part of a study. Inhaled nitric oxide therapy ...
... and can be a cause of Global warming//. ... World’ said: ,"Worldwide reduction of meat production in the pursuit ... carry fewer political unknowns than cutting our consumption of fossil ... and chicken burgers would do more for the environment. ...
Cached Medicine News:Health News:Screening For Prostate Cancer May Reduce Mortality Rate 2
LM-770 Projection Digital Lensmeter...
Autolensmeter with color 5.7 inch LCD screen and built in printer....
Autolensmeter with black/white monitor and no internal printer....
An ideal basic fundus fluorescein camera with quality enhancing features at a mid-range price point. The camera has 1.7x magnification at 60 degree and 2.5x at 40 degree....
Medicine Products: